|
|
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial
Y. Touchefeu
,
R. Guimbaud
,
C. Louvet
,
L. Dahan
,
E. Samalin
et al.
Article dans une revue
hal-01986753v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stefano Kim
,
Eric François
,
Thierry André
,
Emmanuelle Samalin
,
Marine Jary
et al.
Article dans une revue
hal-01863908v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Franck Bonnetain
,
Bert Bonsing
,
Thierry Conroy
,
Adelaide Dousseau
,
Bengt Glimelius
et al.
Article dans une revue
hal-01802621v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty
Dewi Vernerey
,
Amelie Anota
,
Pierre Vandel
,
Sophie Bailly
,
Michele Dion
et al.
Article dans une revue
hal-01444161v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|